Biotech Partnering & Out-licensing Deals: Expediting by Looking Beyond Usual Suspects

How to Expedite Biotech Partnering & Out-Licensing Deals by Looking Beyond Traditional Prospects Partnering and out-licensing are central to the growth of life sciences companies, especially for emerging pharmaceutical and…

Continue ReadingBiotech Partnering & Out-licensing Deals: Expediting by Looking Beyond Usual Suspects

Pharma Business Development: Effectively Leverage Competitive Intelligence for In-licensing Deals

How to Leverage Competitive Intelligence for Smarter In-Licensing Deals for Pharma Business Development and Corporate Development Pharma Business Development and Licensing (BD&L) activities covering pharmaceutical licensing and partnering are integral…

Continue ReadingPharma Business Development: Effectively Leverage Competitive Intelligence for In-licensing Deals

Looking beyond Generics in Commercial Due Diligence of Generics Pharmaceutical Businesses

How to Conduct Robust Commercial Due Diligence by Looking Beyond Generics in Pharma Businesses Investors need to look beyond generics in the pharmaceutical commercial due diligence (CDD) for investment in…

Continue ReadingLooking beyond Generics in Commercial Due Diligence of Generics Pharmaceutical Businesses

Leveraging Medical Conferences to Supercharge Pharma Competitive Intelligence

Why Medical Conferences Are Critical for Pharma Competitive Intelligence Medical conferences (also referred to as medical congresses) are the holy grail for pharmaceutical competitive intelligence teams seeking to gain valuable…

Continue ReadingLeveraging Medical Conferences to Supercharge Pharma Competitive Intelligence

Anticipating Future with Pharma and Diagnostics Competitive Intelligence

Pharma and Diagnostics Competitive Intelligence: How to Anticipate Future Competitive intelligence (CI) is a commonly used decision-making tool in the pharmaceutical industry for seeking competitive advantage. It is often forward-looking…

Continue ReadingAnticipating Future with Pharma and Diagnostics Competitive Intelligence

Determining True Addressable Market in Healthcare and Life Sciences Commercial Due Diligence

How to Accurately Assess the True Addressable Market in Healthcare and Life Sciences Due Diligence Determining the appropriate addressable market is often one of the critical success factors in commercial…

Continue ReadingDetermining True Addressable Market in Healthcare and Life Sciences Commercial Due Diligence